6755 Fallsview Boulevard, Niagara Falls, Ontario, L2G 3W7
This course is Free for CSAM Conference delegates
Registration close Friday 13, October
People who inject drugs (PWIDs) represent approximately 90% of newly acquired hepatitis C infections. Clinicians working with PWID play an important role in improving the health outcomes of people living with hepatitis C by reducing a patient’s risk of developing advanced liver disease through early diagnosis and appropriately managing co-morbidities and treatment with new, curative, Direct Acting Antiviral medications (DAAs).
The course, delivered in three parts, is designed to strengthen the capacity of clinical staff working in primary care and drug and alcohol settings who work with PWIDs to effectively test for, treat and manage hepatitis C. The online learning and face-to-face workshop, delivered by local experts, will give participants the skills to confidently prescribe the new DAAs.
For more information, please contact Sally Cruse – firstname.lastname@example.org
This training has been supported with an unconditional grant by Gilead Sciences Canada Inc.
Online bookings are not available for this event.